FRESH-PEF73378-en
European Cystinosis Cohort
RaDiCo-ECYSCO
| Name | Country code |
|---|---|
| France | fr |
| Belgium | be |
| Italy | it |
| Spain | es |
| Netherlands | nl |
| Germany | de |
['Clinical data','Biological data','Socio-demographic data','Participant-reported health data']
Individuals
| Topic | Vocabulary |
|---|---|
| Ophthalmology | health theme |
| Paediatrics | health theme |
| Nephrology | health theme |
| Disorders of tyrosine metabolism | cim-11 |
| Socio-demographic and economic determinants | health determinant |
| Biological determinants: Genetic predisposition | health determinant |
| Behavioral determinants | health determinant |
| Healthcare system determinants: Use of care | health determinant |
| Biological determinants | health determinant |
| Healthcare system determinants | health determinant |
{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Infant (28 days to 2 years)","concept":{"vocab":"MeSH","vocabURI":"D007223"}},{"value":"Child, Preschool (2 to 5 years)","concept":{"vocab":"MeSH","vocabURI":"D002675"}},{"value":"Child (6 to 12 years)","concept":{"vocab":"MeSH","vocabURI":"D002648"}},{"value":"Adolescent (13 to 18 years)","concept":{"vocab":"MeSH","vocabURI":"D000293"}},{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}},{"value":"Aged (65 to 79 years)","concept":{"vocab":"MeSH","vocabURI":"D000368"}},{"value":"Aged, 80 and over (80 years and more)","concept":{"vocab":"MeSH","vocabURI":"D000369"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"The RaDiCo-ECYSCO Cohort inclusion criteria are the following: • Confirmed diagnosis of cystinosis (based on cystine dosage and/or presence of crystals at eye examination and/or molecular diagnosis) • Signed informed consent ","clusion_E":" Patients not able to give their informed consent. No othercriteria (patients with associated disease should be enrolled)"}
| Name |
|---|
| Aude;SERVAIS |
| Name | Role |
|---|---|
| INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) | sponsor |
| Name |
|---|
| AGENCE NATIONALE DE LA RECHERCHE (ANR) |
| Name |
|---|
| Healthcare Network for Rare Diseases Orkid / European Reference Network ERK-NET |
| Agency name |
|---|
| CNIL |
| CESREES |
['Through organizations (health services or institutions, schools, businesses, etc.)']
['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']
Access on specific project only
Observational Study
| Start | End |
|---|---|
| 2017-01-01 | 2028-01-01 |
| Standard |
|---|
| ['HPO, ICD10, Snomed CT, Orpha Codes and ORDO, Drug dictionary (DCIs)'] |
['Continuous data management; Data Management Plan and Data Validation Plan. Native controls and Query system']
Access Charter. Access requests to RaDiCo-ECYSCO data (rough / structured), or to analytic reports will be examined by the scientific committee following submission of a Specific Research Project (SRP) synopsis, as defined in the Resource Access Charter.
{"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}
| Name | |
|---|---|
| Aude;SERVAIS | aude.servais@aphp.fr |